Sage plans to stop developing dalzanemdor (SAGE-718) for Alzheimer’s after it failed to boost cognitive function in a Phase 2 ...

The biopharmaceutical company isn’t planning further clinical development of dalzanemdor to treat Alzheimer’s.

Sage Therapeutics Inc.’s stock tumbled 12.8% early Tuesday, after the company said a mid-stage trial of a treatment for mild ...

Tuesday, Sage Therapeutics, Inc. (NASDAQ:SAGE) released topline results from the Phase 2 LIGHTWAVE study to evaluate the ...

Sage Therapeutics said its Phase 2 trial of dalzanemdor in patients with mild cognitive impairment or mild dementia due to ...

Sage Therapeutics Inc.’s stock slid 4.7% Thursday, after the biotech said it’s cutting about 33% of its workforce as part of ...

Tests of attention included the Color Trails Test 1 (CTT 1), subtests of Digit Span (DS), Digit Symbol Substitute Test (DSST), Symbol Search (SS) in the Wechsler Adult Intelligence Scale-III (WAIS-III ...

DMIT Test for adults is important. Adulthood is defined by the age of 25 years and above and consists of middle age and old age as well. As an adult, it is safe to say that one has journeyed at least ...

Online autism tests can help you to identify and evaluate autism traits in yourself, a child, a teenager, or another adult. These tests can't confirm a diagnosis, which needs to be made by a qualified ...

Sage Therapeutics announces reorganization, including layoffs and pipeline changes, to support the launch of Zurzuvae. Focus ...